检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:贺琪[1,2] 朱旋[3,2] 皮先明[1,2] 石全[1,2] 李家文[4] 胡枫[5]
机构地区:[1]湖北省中医院皮肤科,武汉430061 [2]湖北省中医药研究院,武汉430074 [3]湖北省中医院泌尿外科,武汉430061 [4]华中科技大学同济医学院附属协和医院皮肤科,武汉430022 [5]武汉市第一医院皮肤科,武汉430030
出 处:《中国麻风皮肤病杂志》2017年第6期328-331,共4页China Journal of Leprosy and Skin Diseases
基 金:武汉市科技局青年科技晨光计划项目(编号:2015071704011621);国家自然科学基金项目(编号:81502735)
摘 要:目的:检测microRNA-155(miR-155)在皮肤扁平苔藓(CLP)中的表达,明确其与辅助性T细胞17/调节性T细胞(Th17/Treg)失衡的相关性。方法:应用TaqMan探针法检测33例CLP患者和25名健康对照者外周血中miR-155,孤儿受体-γt(RORγt),白细胞介素-17A(IL-17A),叉状头/翼状螺旋转录因子P3(Foxp3)和IL-10的基因表达水平。结果:CLP中miR-155,RORγt、Foxp3和IL-17A的表达较对照组显著升高,而IL-10的表达显著降低(均P<0.05);CLP组中,miR-155分别与RORγt、Foxp3和IL-17A的含量显著正相关(均P<0.001),与IL-10的含量无明显相关性(P>0.05)。结论:CLP中的miR-155过表达可能与Th17/Treg失衡有关。Objective: To detect the expression level of microRNA-155 (miR-155) and to determine the relationship with the imbalance of T-helper 17 cell/regulatory T cell (Th17/Treg) in the patients with cutaneous lichen planus (CLP).Methods: The expression of miR-155, retinoid-acid receptor-related orphan receptor gamma (RORγt), interleukin-17A (IL-17A), forkhead box P3 (Foxp3) and IL-10 in peripheral blood of 33 patients with CLP and 25 normal controls were detected by TaqMan probe.Results: Compared with the normal controls, the expression levels of miR-155, RORγt, Foxp3 and IL-17A were higher and the level of IL-10 expression was lower in the CLP patients with CLP (P〈0.05).The level of miR-155 expression was positively correlated with the expression levels of of RORγt, Foxp3 and IL-17A in the patients with CLP (Ps〈0.001).There was no correlation between the expression level of miR-155 and IL-10.Conclusion: The miR-155-upregulation existed in the CLP patients may be associated with the imbalance of Th17/Treg.
关 键 词:microRNA-155 扁平苔藓 辅助性T细胞17 调节性T细胞 白细胞介素-17A
分 类 号:R758.65[医药卫生—皮肤病学与性病学]
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.15